GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BioCube Inc (OTCPK:BICB) » Definitions » Capital Expenditure

BioCube (BioCube) Capital Expenditure : $0.00 Mil (TTM As of Jul. 2013)


View and export this data going back to 2007. Start your Free Trial

What is BioCube Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

BioCube's cash flow for capital expenditures for the three months ended in Jul. 2013 was $0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jul. 2013 was $0.00 Mil.

BioCube Capital Expenditure Historical Data

The historical data trend for BioCube's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCube Capital Expenditure Chart

BioCube Annual Data
Trend Jun06 Jun07 Jan08 Jan09 Jan11 Jan12 Jan13
Capital Expenditure
Get a 7-Day Free Trial -0.55 -0.10 - - -

BioCube Quarterly Data
Apr08 Jul08 Oct08 Jan09 Apr09 Oct09 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioCube Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jul. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCube (BioCube) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BioCube Inc (OTCPK:BICB) » Definitions » Capital Expenditure
Comparable Companies
MBVXQ GWSN BOM:524604 WAR:PFM CTBOD HSTC XSAT:EURI B SOAN GOVX ARGSQ PRTX PTEO BOM:506365 ATMS BOM:524796 TSXV:PBS DTHR BOM:532871 AKAOQ CAPS
Traded in Other Exchanges
N/A
Address
3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119
Website
http://www.biocubeinc.com
BioCube Inc is a shell company.
Executives
Jan E Chason director 120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Jonathan Gilbert director 36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577
Gregory D Cohen director, officer: Chief Executive Officer 336 WEST 37TH STREET, 8TH FLOOR, NEW YORK NY 10019

BioCube (BioCube) Headlines

No Headlines